multicentr
randomis
blind
studi
adult
cow
vaccin
trival
vaccin
market
year
corona
msd
anim
health
rc
prior
last
parturit
revaccin
month
later
prior
upcom
parturit
either
singl
inject
recent
market
vaccin
scour
virbac
bs
rc
aim
trial
verifi
whether
bs
inferior
rc
stimul
immun
respons
passiv
transfer
calv
condit
total
multipar
dairi
cow
differ
herd
locat
countri
franc
uk
germani
enrol
studi
sixtyf
cow
vaccin
bs
rc
antibodi
level
measur
competit
elisa
repres
percentag
inhibit
pi
assess
cow
serum
day
vaccin
day
calv
colostrum
serum
calv
first
week
life
differ
mean
pi
group
confid
interv
ci
calcul
noninferior
threshold
set
relationship
antibodi
level
colostrum
vaccinationcalv
interv
vci
interboost
vaccin
interv
ibvi
also
analys
lower
margin
ci
differ
mean
pi
sampl
pathogen
assess
result
show
bs
inferior
rc
stimul
immun
respons
borv
bocv
e
coli
passiv
transfer
immun
calv
vaccin
administ
dam
previous
vaccin
rc
furthermor
correl
found
pi
valu
colostrum
vci
ibvi
ratio
anim
pi
colostrum
among
cow
similar
interv
significantli
differ
group
antigen
test
therefor
studi
show
singl
inject
heterolog
vaccin
bs
use
booster
cattl
previous
vaccin
rc
neonat
calf
diarrhoea
ncd
affect
mainli
calv
week
age
characteris
diarrhoea
lead
dehydr
acidosi
system
consequ
potenti
lead
death
millemann
preval
ncd
estim
around
diseas
major
caus
death
young
calv
respons
countri
millemann
bartel
et
al
lorenz
et
al
cho
yoon
meganck
et
al
loss
calv
manag
diseas
consequ
health
growth
rate
reproduct
potenti
surviv
calv
lead
signific
econom
loss
millemann
cho
yoon
environ
herd
size
farm
manag
practic
hygien
feed
routin
use
antibiot
neonat
care
colostrum
manag
influenc
ncd
preval
herd
bendali
et
al
bartel
et
al
meganck
et
al
factor
evalu
properli
monitor
avoid
ncd
etiolog
diagnosi
calf
diarrhoea
also
sought
order
limit
consequ
appropri
etiolog
prevent
treatment
millemann
meganck
et
al
meganck
et
al
main
caus
infecti
agent
ncd
especi
calv
day
age
bovin
rotaviru
borv
cryptosporidium
parvum
bovin
coronaviru
respons
calf
diarrhoea
bocvcd
enterotoxigen
escherichia
coli
etec
pathogen
also
respons
diseas
acr
et
al
athanassi
et
al
millemann
cho
yoon
meganck
et
al
clinic
featur
analysi
environ
help
determin
origin
diseas
sever
diagnost
tool
avail
confirm
presenc
one
suspect
pathogen
bendali
et
al
millemann
cho
yoon
differ
strain
serotyp
ncd
caus
agent
identifi
rotavirus
doublestrand
rna
virus
classifi
group
accord
genotyp
inner
capsid
protein
classifi
accord
outer
capsid
protein
mainli
glycoprotein
g
proteasesensit
p
protein
matthijnssen
et
al
ncd
mainli
induc
group
rotavirus
p
p
p
genotyp
predomin
one
cow
snodgrass
et
al
cho
yoon
collin
et
al
europ
preval
borv
diarrheic
calv
vari
higher
preval
seen
area
bartel
et
al
meganck
et
al
mainli
found
calv
week
age
millemann
bartel
et
al
cho
yoon
bovin
coronaviru
bocv
envelop
singlestrand
rna
viru
also
gener
affect
calv
week
age
millemann
boileau
kapil
cho
yoon
patholog
bocv
ncd
often
sever
rotaviru
result
mucohaemorrhag
enterocol
boileau
kapil
preval
pathogen
calv
diarrhoea
gener
around
europ
bartel
et
al
hemagglutininesteras
spike
protein
import
fusion
host
intestin
cell
protein
other
contain
import
neutral
epitop
gener
low
antigen
variabl
clark
tsunemitsu
et
al
boileau
kapil
cho
yoon
among
six
major
diarrhoeagen
e
coli
pathotyp
etec
confirm
main
caus
agent
ncd
kolenda
et
al
pathogen
respons
less
ncd
case
europ
higher
preval
record
elsewher
acr
et
al
bartel
et
al
meganck
et
al
virul
factor
etec
specif
cytotox
toxin
adhesin
debroy
maddox
kolenda
et
al
shown
recent
systemat
review
fimbrial
adhesin
fimbria
heatstabl
enterotoxin
st
significantli
associ
calf
diarrhoea
kolenda
et
al
type
ecoli
usual
affect
young
calv
day
age
lead
rapid
dehydr
cryptosporidium
parvum
protozoan
parasit
frequent
associ
ncd
case
although
infect
also
asymptomat
bartel
et
al
cho
yoon
meganck
et
al
oocyst
excret
faec
surviv
month
environ
resist
disinfect
elimin
pathogen
therefor
challeng
cho
yoon
meganck
et
al
sever
vaccin
develop
etec
rotaviru
coronaviru
commerci
vaccin
avail
c
parvum
yet
cresswel
et
al
vaccin
pregnant
cow
parturit
usual
trigger
immun
respons
lead
presenc
protect
immunoglobulin
colostrum
calf
passiv
protect
stand
rapidli
allow
nurs
satieti
colostrum
fed
properli
kohara
et
al
weaver
et
al
meganck
et
al
vaccin
avail
calf
scour
contain
differ
serotyp
strain
epitop
present
bocv
borv
etec
howev
previou
studi
shown
differ
serotyp
group
borv
share
similar
epitop
heterotyp
immun
respons
occur
alreadi
expos
cattl
mean
vaccin
adult
cow
singl
bovin
rotaviru
serotyp
protect
serotyp
cattl
expos
snodgrass
et
al
brussow
et
al
taniguchi
et
al
crossreact
bocv
strain
even
like
sinc
viru
present
low
antigen
variat
clark
tsunemitsu
et
al
boileau
kapil
final
vaccin
contain
adhesin
main
virul
factor
found
calf
etec
respons
ncd
nagi
feket
debroy
maddox
kolenda
et
al
picco
et
al
therefor
although
demonstr
yet
possibl
use
differ
scour
vaccin
one
use
previou
vaccin
aim
multicentr
randomis
blind
studi
assess
antibodi
respons
borv
bocv
adhesin
adult
cow
vaccin
vaccin
market
year
prior
last
parturit
revaccin
month
later
prior
upcom
parturit
singl
boosterinject
either
vaccin
recent
market
new
vaccin
studi
aim
evalu
antibodi
level
evalu
serum
vaccin
dam
colostrum
serum
newborn
calv
order
evalu
immun
respons
cow
passiv
transfer
calv
result
studi
provid
evid
possibl
effici
use
two
differ
vaccin
success
vaccin
cours
studi
approv
intern
ethic
review
committe
virbac
approv
multicentr
random
blind
referencecontrol
studi
anim
vaccin
last
parturit
rc
revaccin
prior
upcom
parturit
either
bs
rc
immun
respons
passiv
immunis
calv
compar
base
antibodi
level
assess
elisa
found
serum
cow
calv
colostrum
randomis
anim
alloc
either
treatment
group
accord
last
digit
ear
tag
sinc
vaccin
requir
differ
volum
administr
investig
vaccin
pregnant
cow
could
blind
blind
achiev
assign
differ
investig
collect
sampl
healthi
pregnant
cow
differ
herd
locat
countri
franc
uk
germani
pariti
vaccin
ncd
rc
previou
pregnanc
gener
month
depend
calvingconcept
interv
includ
studi
cow
enrol
expect
due
week
vaccin
cow
expect
due
outsid
time
rang
includ
anim
alloc
vaccin
group
bs
group
rc
exclus
made
enrol
even
one
sampl
lack
calv
occur
less
day
vaccin
sampl
taken
twin
born
analys
independ
corona
scour
trival
vaccin
formul
immunis
pregnant
cow
borv
bocv
ecoli
immunogen
ingredi
bs
bovin
rotaviru
strain
serotyp
inactiv
bovin
coronaviru
strain
inactiv
e
coli
strain
inactiv
express
adhesin
adjuv
use
vaccin
waterinoilinwat
commerci
prepar
montanid
isa
vg
seppic
two
inject
last
trimest
pregnanc
requir
primari
vaccin
cours
singl
inject
suffici
boost
immun
statu
previous
vaccin
cow
activ
substanc
rc
bovin
rotaviru
strain
ukcompton
serotyp
inactiv
bovin
coronaviru
strain
mebu
inactiv
e
coli
adhesin
antigen
adjuv
vaccin
aluminium
hydroxid
emulsifi
vaccin
regimen
requir
singl
inject
last
trimest
pregnanc
studi
one
inject
im
vaccin
ml
rc
ml
bs
administ
week
calv
expect
passiv
transfer
immun
recommend
calv
receiv
suffici
amount
colostrum
l
accord
weight
dam
within
h
birth
weaver
et
al
conne
et
al
blood
sampl
collect
coccyg
vein
day
vaccin
day
day
day
parturit
calv
calv
sampl
first
week
life
blood
collect
label
ml
tube
clot
activ
clot
separ
bd
vacutain
sst
ii
advanc
order
prevent
haemolysi
frozen
serum
collect
mainten
blood
sampl
tube
vertic
posit
h
ship
laboratori
analysi
without
addit
label
tube
colostrum
collect
milk
parlour
first
milk
label
steril
ml
plastic
jar
minimum
ml
colostrum
requir
order
prevent
develop
bacteri
contamin
colostrum
sampl
supplement
mg
bronopol
ml
frozen
sent
analysi
titr
antiborv
antibocv
antibodi
assess
measur
inhibit
optic
densiti
inhibit
competit
enzymelink
immunosorb
assay
elisa
serum
colostrum
bio
k
monoscreen
abelisa
rotaviru
bovin
bio
k
monoscreen
abelisa
ecoli
blocag
bio
k
monoscreen
abelisa
coronaviru
bovin
biox
diagnost
belgium
use
indirect
quantif
borv
bocv
antibodi
respect
test
perform
accredit
laboratori
institut
virolog
centr
infecti
diseas
univers
leipzig
leipzig
germani
variabl
record
studi
percentag
inhibit
pi
optic
densiti
assess
competit
elisa
noninferior
bs
vs
rc
pi
valu
assess
use
confid
interv
ci
differ
former
vaccin
latter
assumpt
normal
hold
inhibit
ci
differ
treatment
group
estim
bootstrap
method
bootstrap
perform
repeat
sampl
size
origin
one
done
replac
use
bootstrap
replic
sa
softwar
calcul
ci
bootstrap
data
bootstrap
estim
correspond
percentil
percentil
select
noninferior
bs
compar
rc
infer
lower
bound
ci
differ
group
end
studi
greater
noninferior
margin
intragroup
comparison
perform
use
wilcoxon
signedrank
test
correl
pi
valu
differ
sampl
pi
valu
interv
interboost
vaccin
vaccinationcalv
interv
assess
accord
spearman
rank
correl
coeffici
fisher
exact
test
use
compar
percentag
anim
specif
pi
valu
test
level
twosid
use
multipl
comparison
perform
level
adjust
use
bonferroni
method
cow
vaccin
n
group
n
group
median
min
max
interv
vaccin
previou
one
interboost
vaccin
interv
ibvi
day
day
vaccin
group
bs
group
rc
respect
n
date
previou
vaccin
miss
two
cow
group
median
min
max
interv
vaccin
calv
vaccinationcalv
interv
vci
day
vaccin
group
bs
n
date
miss
cow
exclus
due
calv
less
day
vaccin
day
group
rc
n
date
miss
cow
three
pair
twin
born
group
one
pair
born
group
median
pi
measur
cow
serum
inhibit
group
similar
valu
rang
observ
group
tabl
individu
valu
inhibit
pi
significantli
higher
compar
p
wilcoxon
signedrank
test
except
borv
vaccin
group
rc
signific
differ
observ
tabl
lowest
median
observ
borv
antibodi
highest
median
observ
bocv
antibodi
median
tabl
due
high
pi
median
individu
variat
gener
low
inhibit
tabl
decreas
median
pi
observ
parturit
compar
signific
differ
calv
vs
antigen
vaccin
except
bocv
vaccin
group
rc
tabl
borv
pi
valu
calv
even
significantli
lower
antibodi
pi
valu
still
higher
tabl
colostrum
median
pi
includ
borv
antibodi
tabl
signific
correl
found
ibvi
pi
valu
colostrum
vaccin
antigen
test
spearman
coeffici
compris
n
ns
vci
pi
valu
colostrum
compris
n
ns
tabl
show
vaccin
group
bs
median
pi
colostrum
independ
ibvi
vci
similar
result
obtain
group
rc
except
borv
calv
occur
less
week
vaccin
median
pi
n
tabl
ratio
anim
similar
interv
pi
colostrum
significantli
differ
group
antigen
test
tabl
calf
serum
median
pi
variabl
tabl
lowest
median
observ
borv
antibodi
median
bocv
antibodi
rang
pi
valu
wide
howev
borv
antibodi
pi
valu
vari
instanc
vaccin
group
rc
tabl
suggest
import
individu
variat
serum
cow
tabl
posit
correl
found
pi
valu
obtain
cow
serum
valu
obtain
calf
serum
antigen
assess
vaccin
spearman
coeffici
compris
n
p
borv
bocv
antibodi
posit
correl
also
found
pi
valu
found
colostrum
found
calf
serum
compris
n
p
bocv
tabl
level
antibovin
rotaviru
borv
antibovin
coronaviru
bocv
antibodi
express
light
inhibit
measur
competit
elisa
calv
time
dam
sera
colostra
calv
sera
data
present
median
min
max
mean
antibodi
vaccin
borv
vaccin
group
rc
except
borv
antibodi
group
bs
p
establish
noninferior
bs
compar
rc
differ
mean
pi
observ
either
vaccin
see
tabl
calcul
antigen
cow
serum
calv
variat
vs
colostrum
calf
serum
ci
also
calcul
tabl
virus
antibodi
sampl
variat
assess
lower
valu
ci
inhibit
tabl
show
bs
statist
inferior
rc
studi
assess
cow
vaccin
rc
previou
pregnanc
could
effici
revaccin
singl
inject
bs
induc
immun
respons
inferior
one
found
group
cow
revaccin
rc
immun
respons
evalu
serum
cow
calv
colostrum
evalu
passiv
transfer
assum
calv
fed
properli
colostrum
percentag
inhibit
pi
reflect
antibodi
concentr
assess
competit
elisa
borv
bocv
antibodi
method
chosen
one
commonli
use
accur
way
evalu
antibodi
concentr
differ
sampl
taniguchi
et
al
weaver
et
al
ohlson
et
al
despit
individu
pi
valu
antibodi
median
valu
antibodi
level
assess
borv
bocv
antibodi
inhibit
mainten
high
immun
statu
may
consequ
previou
vaccin
around
month
well
frequent
contact
pathogen
environ
boost
immun
either
vaccin
result
signific
increas
pi
valu
except
borv
antibodi
vaccin
group
rcno
signific
increas
result
show
boost
immun
borv
bocv
etec
achiev
group
bs
cow
previous
vaccin
rc
despit
differ
serotyp
borv
strain
bocv
antigen
present
adhesin
vaccin
result
explain
share
antigen
crossreact
borv
serotyp
bocv
strain
snodgrass
et
al
chiba
et
al
brussow
et
al
clark
tsunemitsu
et
al
inde
previou
studi
found
vaccin
one
borv
serotyp
increas
immun
respons
serotyp
cow
contact
snodgrass
et
al
taniguchi
et
al
concern
antibodi
fact
heterolog
primovaccin
antigen
differ
present
possibl
surpris
similar
result
obtain
antigen
human
lu
compar
mean
mean
variat
bs
found
noninferior
rc
lower
limit
ci
differ
mean
variat
even
borv
antibodi
tabl
suggest
bs
might
even
superior
rc
stimul
immun
respons
viru
differ
could
explain
exampl
use
differ
serotyp
revaccin
better
effici
heterolog
primeboost
vaccin
homolog
one
observ
previous
viral
vector
lu
zhou
et
al
choi
chang
differ
adjuv
could
also
explain
differ
immun
respons
stimul
would
suggest
isa
adjuv
base
purifi
squalen
squalan
present
bs
would
effici
stimul
borv
immun
respons
present
rc
aluminium
hydroxid
light
miner
oilemulsifi
advantag
former
adjuv
demonstr
previous
antigen
patil
et
al
jang
et
al
khorasani
et
al
antibodi
level
cow
serum
calv
lower
decreas
observ
borv
antibodi
greater
one
observ
antibodi
median
pi
calv
even
lower
median
pi
still
bocv
antibodi
result
suggest
less
intens
labil
immun
respons
borv
antigen
assess
decreas
antibodi
cow
serum
calv
observ
previous
due
transport
immunoglobulin
blood
stream
lacteal
secret
colostrogenesi
kohara
et
al
weaver
et
al
murphi
et
al
inde
colostrum
median
pi
group
median
valu
serum
cow
calv
borv
therefor
result
obtain
studi
confirm
high
antibodi
level
reach
colostrum
vaccin
administ
right
time
week
parturit
minimum
week
usual
necessari
vaccin
parturit
allow
immun
respons
reach
maximum
level
around
week
passag
immunoglobulin
mammari
gland
peak
day
parturit
radostit
weaver
et
al
studi
vaccinationcalv
interv
vci
rang
week
median
week
signific
correl
found
vci
antibodi
level
colostrum
howev
borv
antibodi
level
obtain
colostrum
cow
vaccin
rc
less
week
calv
lower
vci
longer
consist
lack
signific
increas
compar
result
suggest
week
requir
immun
respons
borv
fulli
develop
vaccin
analys
correl
ibvi
antibodi
level
colostrum
also
show
two
paramet
link
antigen
assess
mean
singl
inject
bs
rc
least
week
parturit
increas
concentr
specif
immunoglobulin
colostrum
regardless
cow
vaccin
histori
month
studi
level
antibodi
colostrum
great
import
protect
calv
passiv
transfer
correl
level
protect
calv
demonstr
previous
radostit
passiv
transfer
also
highli
depend
amount
colostrum
ingest
calf
time
birth
ingest
advis
recommend
given
farmer
trial
feed
calf
litter
colostrum
accord
calf
weight
first
h
life
transfer
macromolecul
includ
antibodi
across
epitheli
cell
optim
radostit
even
calv
could
suffer
failur
passiv
transfer
fpt
risk
factor
ncd
weaver
et
al
cho
yoon
meganck
et
al
raboisson
et
al
paramet
colostrum
manag
feed
practic
also
involv
fpt
weaver
et
al
meganck
et
al
instanc
fpt
less
like
known
amount
colostrum
given
nippl
bottl
oesophag
tube
bucket
instead
leav
calv
suckl
colostrum
mother
filteau
et
al
trotzwilliam
et
al
farm
includ
studi
colostrum
gener
given
bucket
via
oesophag
tube
limit
risk
fpt
inde
accord
high
level
antibodi
found
calf
serum
median
pi
good
correl
pi
found
serum
cow
colostrum
found
serum
calv
assum
colostrum
given
properli
variabl
antibodi
level
found
serum
calv
therefor
attribut
variabl
found
dam
colostrum
rather
variabl
colostrum
feed
process
like
sampl
mean
pi
found
serum
calv
similar
group
antigen
assess
bs
vaccin
statist
inferior
rc
paramet
sinc
calf
diarrhoea
due
borv
bocv
etec
infect
also
due
infect
virus
like
bovin
viral
diarrhoea
viru
bacteria
like
salmonella
parasit
like
c
parvum
millemann
cho
yoon
preval
calf
diarrhoea
offspr
vaccin
cow
record
howev
high
pi
valu
found
calv
vaccin
cow
studi
suggest
calv
protect
affect
induc
borv
bocv
etec
radostit
therefor
although
vaccin
use
sole
prevent
intervent
especi
protect
pathogen
remain
effici
way
protect
calv
main
pathogen
ncd
radostit
kohara
et
al
bendali
et
al
cho
yoon
meganck
et
al
meganck
et
al
data
obtain
studi
show
vaccin
multipar
pregnant
dairi
cow
either
rc
bs
vaccin
rc
previou
pregnanc
give
similar
result
term
antibodi
level
serum
cow
calv
colostrum
bs
vaccin
found
statist
noninferior
rc
paramet
despit
differ
serotyp
strain
antigen
present
two
vaccin
studi
also
confirm
effici
passiv
transfer
immun
achiev
vaccin
dam
colostrum
intak
properli
manag
find
singl
inject
bs
use
booster
cattl
previous
vaccin
anoth
scour
vaccin
facilit
prophylact
vaccin
campaign
field
especi
vaccin
shortag
occur
anoth
vaccin
one
previous
use
must
chosen
financi
reason
first
author
l
durel
well
c
rose
j
bennemann
employe
virbac
animal
affili
virbac
produc
commerci
licens
vaccin
control
ncd
research
report
paper
support
virbac
animal
carro
franc
compani
financi
interest
subject
matter
discuss
manuscript
first
author
l
durel
well
c
rose
j
bennemann
employe
virbac
animal
affili
virbac
produc
commerci
licens
vaccin
control
ncd
